2013
DOI: 10.2478/s13380-013-0108-3
|View full text |Cite
|
Sign up to set email alerts
|

The olfactory system in Alzheimer’s disease: Pathology, pathophysiology and pathway for therapy

Abstract: Olfaction is frequently mentioned as a "neglected sense", although the olfactory system has several interesting and unique anatomical and physiological features. Olfactory involvement is present in several degenerative disorders, especially in Alzheimer's disease (AD). The peripheral and central parts of the olfactory system are damaged even in the early stages of AD, manifesting in profound olfactory deficits. Besides the early pathology, the olfactory system may be involved in the pathogenesis of AD by provi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0
1

Year Published

2014
2014
2020
2020

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(11 citation statements)
references
References 151 publications
0
10
0
1
Order By: Relevance
“…They are also thankful for valuable comments provided by Khalid Iqbal, PhD (New York In contradistinction to the pathology that emerges in the course of sporadic Parkinson's disease (PD) (Braak and Del Tredici 2009;Del Tredici et al 2010;Del Tredici and Braak 2012), the hallmark lesions associated with AD remain almost exclusively confined to the CNS. Nerve cells of the peripheral and enteric nervous systems (PNS, ENS) likewise contain normal tau and the amyloid precursor protein (APP), but only the olfactory epithelium is known to develop abnormal protein aggregates (Arnold et al 2010;Kovács 2013). Why is it that the ENS and other PNS sites do not develop aggregated tau and Aβ?…”
Section: Prefacementioning
confidence: 99%
“…They are also thankful for valuable comments provided by Khalid Iqbal, PhD (New York In contradistinction to the pathology that emerges in the course of sporadic Parkinson's disease (PD) (Braak and Del Tredici 2009;Del Tredici et al 2010;Del Tredici and Braak 2012), the hallmark lesions associated with AD remain almost exclusively confined to the CNS. Nerve cells of the peripheral and enteric nervous systems (PNS, ENS) likewise contain normal tau and the amyloid precursor protein (APP), but only the olfactory epithelium is known to develop abnormal protein aggregates (Arnold et al 2010;Kovács 2013). Why is it that the ENS and other PNS sites do not develop aggregated tau and Aβ?…”
Section: Prefacementioning
confidence: 99%
“…Olfactory dysfunction significantly impairs physical well-being, quality of life, enjoyment of food, everyday safety, and is associated with increased mortality in older adults [15,16]. Multiple (morphological) substrates of olfactory dysfunction have been identified, such as an increased propensity for nasal disease as well as anatomical and functional changes at multiple levels of the olfactory system, including the olfactory epithelium (OE), olfactory bulb (OB), primary olfactory cortices, their secondary targets, and the olfactory circuitry [2,3,12,17]. Impaired odour identification in old age has strong practical implications on daily life activities as it is associated with a decrease in global cognition and a decline in episodic memory [18].…”
Section: Introductionmentioning
confidence: 99%
“…The aberrant accumulation of misfolded proteins can trigger several side effects, causing a transduction deficit and inflammatory responses attempting to reduce/avoid the microbial diffusion into the brain. Based on the absence of the BBB in the olfactory tract, cells and misfolded proteins can be easily propagated within the brain and subsequently affect other olfactory system components, as olfactory cortices and connected areas (hippocampus and amygdala) [233]. All these cerebral structures and their related functions are damaged in AD, and to a lesser extent in normal aging [42].…”
Section: Progressive Neurodegenerative Disordersmentioning
confidence: 99%